作者: Brian P. Kearney , Rebecca Restituto Begley , Joseph Marcello Custodio
DOI:
关键词:
摘要: The disclosure describes methods for treatment of patients co-infected with HIV and tuberculosis, wherein the patient receives effective amounts elvitegravir, an antimycobacterial agent a CYP inhibitor.